AAAAAA

   
Results: 1-12 |
Results: 12

Authors: Nemeth, EF Delmar, EG Heaton, WL Miller, MA Lambert, LD Conklin, RL Gowen, M Gleason, JG Bhatnagar, PK Fox, J
Citation: Ef. Nemeth et al., Calcilytic compounds: Potent and selective Ca2+ receptor antagonists that stimulate secretion of parathyroid hormone, J PHARM EXP, 299(1), 2001, pp. 323-331

Authors: Ishii, H Wada, M Furuya, Y Nagano, N Nemeth, EF Fox, J
Citation: H. Ishii et al., Daily intermittent decreases in serum levels of parathyroid hormone have an anabolic-like action on the bones of uremic rats with low-turnover bone and osteomalacia, BONE, 26(2), 2000, pp. 175-182

Authors: Chin, J Miller, SC Wada, M Nagano, N Nemeth, EF Fox, J
Citation: J. Chin et al., Activation of the calcium receptor by a calcimimetic compound halts the progression of secondary hyperparathyroidism in uremic rats, J AM S NEPH, 11(5), 2000, pp. 903-911

Authors: Wada, M Nagano, N Furuya, Y Chin, J Nemeth, EF Fox, J
Citation: M. Wada et al., Calcimimetic NPS R-568 prevents parathyroid hyperplasia in rats with severe secondary hyperparathyroidism, KIDNEY INT, 57(1), 2000, pp. 50-58

Authors: Gowen, M Stroup, GB Dodds, RA James, IE Votta, BJ Smith, BR Bhatnagar, PK Lago, AM Callahan, JF DelMar, EG Miller, MA Nemeth, EF Fox, J
Citation: M. Gowen et al., Antagonizing the parathyroid calcium receptor stimulates parathyroid hormone secretion and bone formation in osteopenic rats, J CLIN INV, 105(11), 2000, pp. 1595-1604

Authors: Straub, SG Kornreich, B Oswald, RE Nemeth, EF Sharp, GWG
Citation: Sg. Straub et al., The calcimimetic R-467 potentiates insulin secretion in pancreatic beta cells by activation of a nonspecific cation channel, J BIOL CHEM, 275(25), 2000, pp. 18777-18784

Authors: Fox, J Lowe, SH Conklin, RL Nemeth, EF
Citation: J. Fox et al., The calcimimetic NPS R-568 decreases plasma PTH in rats with mild and severe renal or dietary secondary hyperparathyroidism, ENDOCRINE, 10(2), 1999, pp. 97-103

Authors: Wada, M Nagano, N Nemeth, EF
Citation: M. Wada et al., The calcium receptor and calcimimetics, CURR OP NEP, 8(4), 1999, pp. 429-433

Authors: Nemeth, EF Fox, J
Citation: Ef. Nemeth et J. Fox, Calcimimetic compounds: A direct approach to controlling plasma levels of parathyroid hormone in hyperparathyroidism, TRENDS ENDO, 10(2), 1999, pp. 66-71

Authors: Hammerland, LG Krapcho, KJ Garrett, JE Alasti, N Hung, BCP Simin, RT Levinthal, C Nemeth, EF Fuller, FH
Citation: Lg. Hammerland et al., Domains determining ligand specificity for Ca2+ receptors, MOLEC PHARM, 55(4), 1999, pp. 642-648

Authors: Fox, J Lowe, SH Petty, BA Nemeth, EF
Citation: J. Fox et al., NPS R-568: A type II calcimimetic compound that acts on parathyroid cell calcium receptor of rats to reduce plasma levels of parathyroid hormone and calcium, J PHARM EXP, 290(2), 1999, pp. 473-479

Authors: Fox, J Lowe, SH Conklin, RL Petty, BA Nemeth, EF
Citation: J. Fox et al., Calcimimetic compound NPS R-568 stimulates calcitonin secretion but selectively targets parathyroid gland Ca2+ receptor in rats, J PHARM EXP, 290(2), 1999, pp. 480-486
Risultati: 1-12 |